PPT-Pharmacist Prescriptive Authority for Tuberculosis Testing

Live Case Discussion and Admin Practice Offered by the New Mexico Pharmacists Association Disclosure The parties involved in creation and development of the New Mexico Pharmacists Prescriptive Authority have nothing to disclose. When someone who is sick with TB coughs speaks laughs sings or sneezes people nearby may breathe TB bacteria into their lungs TB usually attacks the lungs but can also attack other parts of the body such as the brain spine or kidneys There are two t FAX 501.686.2714www.arsbn.org AddressMailing Address CERTICICATE OC PRESCRIPTIVE AUTHORITY APPLICATIONARKANSAS STATE BOARD OC NURSINGUNIVERSITY TOWER BUILDING1123 SOUTH UNIVERSITY, SUITE 800LITTLE ROC Before and After November 1, 2013 Lynda Woolbert, MSN, RN, CPNP - PC, FAANP SB 406 is the new prescriptive authority law governing delegation of prescriptive authority to Advanced Practice Registered TB Program Manager. New Mexico. TB ETN/PEN 2012. Doorway to a New Era. Pharmacists as Public Health Partners. NM Pharmacist Association contacted TB program – Considering prescriptive authority for pharmacists to place TSTs. Treatment of Latent TB Infection. December 2011. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Division of Tuberculosis Elimination. Targeted TB Testing . and Treatment of Latent TB Infection. Treatment of Latent TB Infection. September 2016. Targeted TB Testing and Treatment of Latent TB Infection. As TB disease rates in the United States decrease, finding and treating persons at high risk for latent TB infection (LTBI) has become a priority.. Targeted Testing and . the Diagnosis of . Latent Tuberculosis . Infection and . Tuberculosis Disease. Module 3 – Targeted Testing and the Diagnosis of . Latent Tuberculosis Infection and Tuberculosis Disease. . Live Session. Offered by the New Mexico Pharmacists Association. Disclosure. The parties involved in creation and development of the New Mexico Pharmacists Prescriptive Authority have nothing to disclose. Bradley Allen, MD, PhD, FACP, FIDSA. Indiana University School of Medicine. Division of Infectious Diseases. Roudebush VAMC. Indianapolis. March 2017. Disclosures. Medical Consultant, TB Control Program. Krystalyn Weaver, PharmD. VP, Policy & Operations. National Alliance of State Pharmacy Associations. Disclosure. I . do not have (nor does any immediate family member have) actual or potential conflict of interest, within the last twelve months; a vested interest in or affiliation with any corporate organization offering . MSN, APRN, FNP . Disclosures. President, Texas Board of Nursing (BON). Presentation was prepared with the assistance of BON staff. It is the policy of the BON to ensure balance, independence, objectivity and scientific rigor in all of its continuing nursing education activities. Pharmacist . Prescriptive Authority Trends. Krystalyn Weaver, PharmD. VP, Policy & Operations. National Alliance of State Pharmacy Associations. Definitions of Prescribing Activities. Activity. Definition. of Practice. Krystalyn Weaver, PharmD. VP, Policy & Operations. National Alliance of State Pharmacy Associations. Disclosure. I . do not have (nor does any immediate family member have) actual or potential conflict of interest, within the last twelve months; a vested interest in or affiliation with any corporate organization offering . Tuberculosis Laboratory Aggregate Report ii Suggested Citation: CDC. Fourth Edition of the Tuberculosis Laboratory Aggregate Report, Atlanta, Georgia: U.S. Department of Health and Human Services, C